UPLOAD Filing
Esperion Therapeutics, Inc.
Date: April 23, 2025 · CIK: 0001434868 · Accession: 0000000000-25-004313
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286631
Letter
Re: Esperion Therapeutics, Inc. Registration Statement on Form S-3 Filed April 18, 2025 File No. 333-286631 Dear Sheldon L. Koenig:
April 23, 2025
Sheldon L. Koenig Chief Executive Officer Esperion Therapeutics, Inc. 3891 Ranchero Drive, Suite 150 Ann Arbor, MI 48108
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Adam Johnson, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 23, 2025 Sheldon L. Koenig Chief Executive Officer Esperion Therapeutics, Inc. 3891 Ranchero Drive, Suite 150 Ann Arbor, MI 48108 Re: Esperion Therapeutics, Inc. Registration Statement on Form S-3 Filed April 18, 2025 File No. 333-286631 Dear Sheldon L. Koenig: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Adam Johnson, Esq. </TEXT> </DOCUMENT>